Market driven healthcare is massively divisive. Opponents argue that a competition approach to medical treatment negatively impacts on quality, while advocates point to increased efficiencies. This book casts a critical eye over both positions to show that the concerns over quality are in fact real. Taking a two part approach, it unveils the fault lines along which healthcare provision and the pursuit of quality would in certain cases clash. It then shows how competition authorities can only effectively assess competition concerns when they ask the fundamental question of how the concept of healthcare quality should be defined and factored into their decisions. Drawing on UK, US and EU examples, it explores antitrust and merger cases in hospital, medical and health insurance markets to give an accurate depiction of the reality and challenges of regulating competition in healthcare provision.
Rezensionen / Stimmen
Professor Stavroulaki's book is sophisticated and well done ... This interdisciplinary and comparative perspective is important in analysing to what extent the UK and EU should follow the US approach, as all three jurisdictions seek to inject more market competition into their existing healthcare systems. -- Spencer Weber Waller, Loyola University Chicago School of Law * World Competition * A timely and relevant book contemplating the (correct) application of competition law when it comes to healthcare. -- Christian Bergqvist, University of Copenhagen * European Competition Law Review *
Reihe
Sprache
Verlagsort
Verlagsgruppe
Bloomsbury Publishing PLC
Zielgruppe
Für höhere Schule und Studium
Maße
Höhe: 240 mm
Breite: 161 mm
Dicke: 20 mm
Gewicht
ISBN-13
978-1-5099-4334-0 (9781509943340)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Theodosia Stavroulaki is Assistant Professor of Law at Gonzaga University School of Law, USA.
Autor*in
Gonzaga University, USA
1. Setting the Scene: What is Healthcare Quality?
I. How is Healthcare Quality Defined
II. Deconstructing the Notion: What are the Main Dimensions of Healthcare Quality?
III. Choosing the Core Dimensions of Healthcare Quality: Why is it Essential?
IV. Levels of Analysis in the Concept of Quality
V. How is Healthcare Quality Measured?
VI. Structure, Process and Outcome: When to Use What?
VII. Summing Up
2. Introducing Competition in Healthcare: What are the Risks to Healthcare Quality?
I. Towards the Marketisation of EU Health Systems: What is the Rationale Behind this Trend?
II. Is the Market for Healthcare Special?
III. Applying Competition Law with a View to Protecting Healthcare Quality: What are the Challenges?
IV. Summing Up
3. The Market Approach: Part I
I. Professionalism versus Antitrust: What is the Debate About?
II. Do the US Antitrust Enforcers and the Courts Take into Account Healthcare Quality?
III. Do the US Antitrust Enforcers and the Courts Balance Conflicts Between Different Quality Perspectives?
IV. Summing Up
4. The Market Approach: Part II
I. How are Hospitals Paid? A Historical Perspective
II. Hospital Merger Analysis: A Short Journey to the Applicable Competition Framework
III. Quality in the US Hospital Merger Analysis
IV. Incorporating Healthcare Quality Claims into a Merger Analysis: A Mission Impossible?
V. Summing Up
5. The Holistic Approach
I. Health Systems in Europe: What are their Common Values and Objectives?
II. Conflicts between the Goals of Competition and the Multiple Facets of Healthcare Quality: Reflections on the English Health System
III. Protecting Healthcare Quality under EU Competition Law
IV. How can Healthcare Quality be Evaluated as a Whole?
V. Summing Up
6. The Regulatory Approach
I. An Introduction to the Main Facets of the HSCA 2012: How Does this Framework Force Hospitals to Merge?
II. How and to What Extent Does the CMA Integrate Quality Concerns in the Context of NHS Mergers?
III. Evaluating the CMA's Approach as a Whole: What are the Aspects of Quality the CMA Considers in its Merger Assessment?
IV. Summing Up
7. Reflections
I. The Book's Core Findings
II. Integrating Healthcare Quality as a Whole: Mission Impossible?
III. Looking Towards the Future: Antitrust in the Era of Data Driven Mergers in the Healthcare Field
